BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 216 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,853,000 | -48.5% | 45,333 | -50.4% | 0.00% | -40.0% |
| Q2 2022 | $13,312,000 | +35.9% | 91,363 | +10.6% | 0.01% | +66.7% |
| Q1 2022 | $9,794,000 | +33.6% | 82,599 | +55.3% | 0.00% | +50.0% |
| Q4 2021 | $7,330,000 | -28.9% | 53,186 | -28.3% | 0.00% | -33.3% |
| Q3 2021 | $10,303,000 | +538.0% | 74,176 | +346.0% | 0.00% | +200.0% |
| Q2 2021 | $1,615,000 | +42.2% | 16,633 | +0.0% | 0.00% | – |
| Q1 2021 | $1,136,000 | -50.8% | 16,625 | -38.3% | 0.00% | -100.0% |
| Q4 2020 | $2,311,000 | +20.1% | 26,960 | -8.9% | 0.00% | 0.0% |
| Q3 2020 | $1,925,000 | – | 29,608 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 490,422 | $12,755,876 | 13.24% |
| FNY Investment Advisers, LLC | 30 | $0 | 0.00% |